Printer Friendly

ALLERCARE ANNOUNCES SALE OF LASALLE' '10' BUSINESS AND SECOND QUARTER RESULTS

 BLOOMINGTON, Minn., Dec. 10 /PRNewswire/ -- Allercare, Inc. (OTC Bulletin Board: ALLR), today announced that on Dec. 2, 1993, the sale of its LaSalle' "10" business was approved at the annual shareholders' meeting and that the transaction was finalized and the proceeds from the sale were disbursed on Dec. 8, 1993. In addition, on Dec. 2, 1993, the shareholders voted to liquidate the company after completion of the sale.
 The company also announced results for the fiscal second quarter ended Oct. 31, 1993. Comparisons to last year are not meaningful as the above sale was effective Sept. 3, 1993.
 Net sales for the quarter ended Oct. 31, 1993, were $77,692 down from $309,165 in the prior year, a decrease of 75 percent. Net sales for the six-months ended Oct. 31, 1993, were $412,135 down from $721,748 in the prior year, a decrease of 43 percent.
 The net loss for the quarter was $84,570, or $0.01 loss per share versus net income last year of $4,013, or $0.00 per share. The net loss for the first six months was $204,903, or $0.02 per share versus a net loss last year of $53,968, or $0.01 per share.
 Last year's results included a $446,620 charge for debt conversion expense and an extraordinary gain of $481,710 from the extinguishment of customer debt.
 ALLERCARE, INC.
 SUMMARY OF RESULTS
 FISCAL SECOND QUARTER AND FIRST SIX MONTHS
 Quarter Ended Six Months Ended
 10/31/93 10/31/92 10/31/93 10/31/92
 Net sales $77,692 $309,165 $412,135 $721,748
 Income (loss) before
 extraordinary items (84,540) (28,437) (204,903) (535,678)
 Extraordinary item -- 32,450 -- 481,710
 Net income (loss) $(84,570) $4,013 $204,903 $(53,968)
 Net income (loss) per
 share before
 extraordinary items (0.01) -- (0.02) (0.06)
 Extraordinary item
 per share -- -- -- 0.05
 Net income (loss)
 per share $(0.01) -- $(0.02) $(0.01)
 Weighted average
 shares outstanding 9,594,727 9,444,727 9,552,336 8,823,430
 -0- 12/10/93
 /CONTACT: Sigfred W. Peck, president and CEO, of Allercare, 612-338-8714/


CO: Allercare, Inc. ST: Minnesota IN: SU: ERN

DB-AL -- MN010 -- 2818 12/10/93 17:36 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 10, 1993
Words:378
Previous Article:SIENNA TECHNOLOGIES AGREES TO SELL ASSETS TO AETRIUM INCORPORATED
Next Article:FIRST MIDWEST FINANCIAL REPORTS FISCAL YEAR EARNINGS
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters